A detailed history of Canada Pension Plan Investment Board transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 67,000 shares of RYTM stock, worth $4.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67,000
Previous 417,000 83.93%
Holding current value
$4.16 Million
Previous $17.1 Million 79.5%
% of portfolio
0.0%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.81 - $55.0 $14.3 Million - $19.3 Million
-350,000 Reduced 83.93%
67,000 $3.51 Million
Q2 2024

Aug 12, 2024

SELL
$35.41 - $44.37 $5.67 Million - $7.1 Million
-160,000 Reduced 27.73%
417,000 $17.1 Million
Q1 2024

May 14, 2024

BUY
$39.12 - $52.44 $12.1 Million - $16.3 Million
310,000 Added 116.1%
577,000 $25 Million
Q4 2023

Feb 14, 2024

BUY
$21.39 - $49.64 $5.71 Million - $13.3 Million
267,000 New
267,000 $12.3 Million

Others Institutions Holding RYTM

About RHYTHM PHARMACEUTICALS, INC.


  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $3.46B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.